PURPOSE: Most of the 182,460 women diagnosed with breast cancer in the United States this year will become long-term survivors. Helping these women transition from active treatment to survivorship is a challenge that involves both oncologists and primary care physicians (PCPs). This study aims to describe postmenopausal breast cancer survivors' (BCS) perceptions of PCP-related survivorship care. PATIENTS AND METHODS: We conducted a cross-sectional survey of 300 BCSs seen in an outpatient breast oncology clinic at a large university hospital. The primary outcome measure was a seven-item self-reported measure on perceived survivorship care (Cronbach's alpha = .89). Multivariate regression analyses were used to identify factors associated with perceived care delivery. RESULTS: Overall, BCSs rated PCP-related survivorship care as 65 out of 100 (standard deviation = 17). The areas of PCP-related care most strongly endorsed were general care (78%), psychosocial support (73%), and health promotion (73%). Fewer BCSs perceived their PCPs as knowledgeable about cancer follow-up (50%), late effects of cancer therapies (59%), or treating symptoms related to cancer or cancer therapies (41%). Only 28% felt that their PCPs and oncologists communicated well. In a multivariate regression analysis, nonwhite race and level of trust in the PCP were significantly associated with higher perceived level of PCP-related survivorship care (P = .001 for both). CONCLUSION: Although BCSs perceived high quality of general care provided by their PCPs, they were not as confident with their PCPs' ability to deliver cancer-specific survivorship care. Interventions need to be tested to improve oncology-primary care communication and PCP knowledge of cancer-specific survivorship care.
PURPOSE: Most of the 182,460 women diagnosed with breast cancer in the United States this year will become long-term survivors. Helping these women transition from active treatment to survivorship is a challenge that involves both oncologists and primary care physicians (PCPs). This study aims to describe postmenopausal breast cancer survivors' (BCS) perceptions of PCP-related survivorship care. PATIENTS AND METHODS: We conducted a cross-sectional survey of 300 BCSs seen in an outpatient breast oncology clinic at a large university hospital. The primary outcome measure was a seven-item self-reported measure on perceived survivorship care (Cronbach's alpha = .89). Multivariate regression analyses were used to identify factors associated with perceived care delivery. RESULTS: Overall, BCSs rated PCP-related survivorship care as 65 out of 100 (standard deviation = 17). The areas of PCP-related care most strongly endorsed were general care (78%), psychosocial support (73%), and health promotion (73%). Fewer BCSs perceived their PCPs as knowledgeable about cancer follow-up (50%), late effects of cancer therapies (59%), or treating symptoms related to cancer or cancer therapies (41%). Only 28% felt that their PCPs and oncologists communicated well. In a multivariate regression analysis, nonwhite race and level of trust in the PCP were significantly associated with higher perceived level of PCP-related survivorship care (P = .001 for both). CONCLUSION: Although BCSs perceived high quality of general care provided by their PCPs, they were not as confident with their PCPs' ability to deliver cancer-specific survivorship care. Interventions need to be tested to improve oncology-primary care communication and PCP knowledge of cancer-specific survivorship care.
Authors: Lisa A Schwartz; Jun J Mao; Branlyn W Derosa; Jill P Ginsberg; Wendy L Hobbie; Claire A Carlson; Ifigenia D Mougianis; Sue K Ogle; Anne E Kazak Journal: J Am Board Fam Med Date: 2010 May-Jun Impact factor: 2.657
Authors: Erica L Mayer; Adrienne B Gropper; Bridget A Neville; Ann H Partridge; Danielle B Cameron; Eric P Winer; Craig C Earle Journal: J Clin Oncol Date: 2011-12-12 Impact factor: 44.544
Authors: Jessica R Schumacher; Whitney P Witt; Mari Palta; Noelle K Loconte; Susan M Heidrich; Amy Trentham-Dietz; Nancy Pandhi; Maureen A Smith Journal: J Am Board Fam Med Date: 2012 Jul-Aug Impact factor: 2.657
Authors: Eric S Zhou; Sharon L Bober; Larissa Nekhlyudov; Jim C Hu; Philip W Kantoff; Christopher J Recklitis Journal: Patient Educ Couns Date: 2016-07-14
Authors: Jun J Mao; Annie Chung; Adrian Benton; Shawndra Hill; Lyle Ungar; Charles E Leonard; Sean Hennessy; John H Holmes Journal: Pharmacoepidemiol Drug Saf Date: 2013-01-16 Impact factor: 2.890